CDX-2 should be included in the work-up of patients with lung metastases from unknown primary.
Fazio
N
N
De Pas
T
T
de Braud
F
F
Spaggiari
L
L
Mazzarol
G
G
Biffi
R
R
Andreoni
B
B
Zampino
M
M
Curigliano
G
G
Lorizzo
K
K
Di Meglio
G
G
Goldhirsch
A
A
D000230:Adenocarcinoma / Q000175:diagnosis / Q000556:secondary*; D014408:Biomarkers, Tumor / Q000032:analysis*; D000071616:CDX2 Transcription Factor; D003110:Colonic Neoplasms / Q000175:diagnosis / Q000473:pathology*; D003937:Diagnosis, Differential; D018398:Homeodomain Proteins / Q000032:analysis* / Q000096:biosynthesis; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000175:diagnosis*; D015534:Trans-Activators / Q000032:analysis* / Q000096:biosynthesis
D014408:Biomarkers, Tumor; D000071616:CDX2 Transcription Factor; D018398:Homeodomain Proteins; D015534:Trans-Activators